Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.

about

Brief Report: Medication Sharing Is Rare Among African HIV-1 Serodiscordant Couples Enrolled in an Efficacy Trial of Oral Pre-exposure Prophylaxis (PrEP) for HIV-1 Prevention.

Item

http://www.wikidata.org/entity/Q38850925

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Brief Report: Medication Shari ...... s (PrEP) for HIV-1 Prevention.

@en

type

Item

label

Brief Report: Medication Shari ...... s (PrEP) for HIV-1 Prevention.

@en

prefLabel

Brief Report: Medication Shari ...... s (PrEP) for HIV-1 Prevention.

@en

P1476

Brief Report: Medication Shari ...... s (PrEP) for HIV-1 Prevention.

@en

P2093

Allan Ronald

http://www.w3.org/2001/XMLSchema#string

Andrew Mujugira

http://www.w3.org/2001/XMLSchema#string

Craig W Hendrix

http://www.w3.org/2001/XMLSchema#string

Jared M Baeten

http://www.w3.org/2001/XMLSchema#string

Jessica E Haberer

http://www.w3.org/2001/XMLSchema#string

Kerry A Thomson

http://www.w3.org/2001/XMLSchema#string

Mark A Marzinke

http://www.w3.org/2001/XMLSchema#string

Partners PrEP Study Team

http://www.w3.org/2001/XMLSchema#string

Patrick Ndase

http://www.w3.org/2001/XMLSchema#string

P2860

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.

HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.

The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.

Pretreatment antiretroviral exposure from recreational use

Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda

Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

P304

184-189

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000001356

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Connie Celum

David R Bangsberg

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28291050

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

5432041

http://www.w3.org/2001/XMLSchema#string